It’s déjà vu all over again. Just as the kidney disease space becomes increasingly competitive, Novartis has found itself intending to turn a statistical miss into a regulatory win. | It’s déjà vu all ...

Adults living with idiopathic hypersomnia and narcolepsy type 1 often report cognitive difficulties, including problems with memory, attention, and mental fatigue. However, new research published in ...

PROPEL 3 successfully met the primary endpoint of change from baseline in AHV at Week 52 (p - Change from baseline in AHV was superior to placebo at Week 52 with a mean treatment difference against ...

Hot nights during pregnancy tied to autism in study tracking 300,000 births. Risk increased during specific developmental ...

The Fetal Medicine Foundation (FMF) method for early risk assessment and aspirin prophylaxis showed no significant reduction ...

Once a top prospect, Zac Veen has opened up about his struggles and why he has done a complete turnaround this offseason.

Speed-of-processing training with booster sessions was tied to a lower dementia risk over a 20-year period. Memory and ...

Retrospective analysis compares smooth and perforated polyetheretherketone implants, revealing trends in postoperative ...

An fresh look at trial results that propelled the only FDA approval of a chimeric antigen receptor (CAR) T-cell therapy for mantle cell lymphoma (MCL) shows prior treatment with ibrutinib, a ...

DANYANG, JIANGSU, CHINA, January 22, 2026 /EINPresswire.com/ -- The modern digital landscape has fundamentally altered ...

ORLANDO - When reviewing the stats from Wednesday’s game in Miami, you won’t notice too many differences. Both the Magic and Heat shot 50 percent from the field overall. The Heat shot it slightly ...

Peer-reviewed Phase 2 Results Inform Ongoing Phase 3/Pivotal Trial of Celeste® in Parkinson’s Disease The Phase 2 study ...